This increased cost on patented molecules was a major hindrance for access to medicine. Public health officials considered Doha Declaration on compulsory licensing a positive approach in prioritizing public health over intellectual property rights. (Jain, 2009)K. KumariAjay SharmaThe Journal of medical research
Abbott F. M., "Compulsory Licensing for Public Health Needs: The TRIPS Agenda at the WTO after the Doha Declaration on Public Health", Quaker United Nations Office, Occasional Paper No 9, Geneva 2008.Abbott, Frederick "Compulsory Licensing for Public Health Needs: The TRIPS Agenda at the ...
2007. The texts represented what the chair of each committee, as facilitators of the talks, believed was the basis for a balanced level of concessions based on the Doha Declaration and subsequent agreements. Revisions to these
Murthy, Divya, The Future of Compulsory Licensing: Deciphering the Doha Declaration on the TRIPS Agreement and Public Health, 17 American University Intemational Law Review 1299, 5 (2002).The future of compulsory licensing: deciphering the Doha Declaration on the TRIPS Agreement and public health. ...
The Doha Declaration states that the TRIPS agreement does not and should not prevent members from taking measures to protect public health. It allows the use of compulsory licensing.ten Have, HenkDuquesne UniversityPatro Neves, Maria do Céu
AIDSAfricaCompulsory LicensingGeneric DrugsIn today's world, there is a lot of focus on issues such as militancy, global warming, terrorism, racism and even politics. Unfortunately, there is a problem thdoi:10.2139/ssrn.1719555Ufuoma Barbara Akpotaire...
Rainey, Broad-Based Compulsory Licensing of Pharmaceutical TechnologiesRajkumar, RahulAlb.l.j.sci. & TechRJKUMAR,RAHUL.The Central American Free Trade Agreement: An End Run around the Doha Declaration on TRIPS and Public Health.Alb.L.J.Sei.&Tech. 2005...
Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health (2001) recognized the difficulty of some WTO member states in using the compulsory licensing flexibility allowed in the TRIPS Agreement due to their lack of local pharmaceutical manufacturing capacities. However, there has ...
(2011). Compulsory Licensing And Access To Medicines In Post Doha Era: What Hope For Africa? Journal of Intellectual Property Law2. Retrieved on February 13, 2012, from http://web.ebscohost.com/ehost/results?sid=b06a26af-6028-4687-93e0- 06fa097c0197%40sessionmgr13&vid=19&hid=122&b...
Reports on the November 2000 declaration in Doha, Qatar that countries could override pharmaceutical patents to gain faster, cheaper access to medicines in certain situations. Why the declaration is not irrelevant; Way of drug companies to avert the threat of compulsory licensing.Kolker...